FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Reportedly Studying Anti-epileptic Equivalence

[ Price : $8.95]

Attorney Kurt Karst says that a 2010 report to Congress should help resolve questions about the bioequivalence of branded and gene...

FDA Extends Review of IV Acetaminophen

[ Price : $8.95]

FDA extends by three months its review of a Cadence Pharmaceuticals NDA for intravenous (IV) acetaminophen.

Torgerson Debarred

[ Price : $8.95]

Federal Register Notice: FDA issues an order debarring Michelle Lynn Torgerson from providing services in any capacity to a person...

Public Docket on LASIK Info Reopened

[ Price : $8.95]

Federal Register Notice: FDA reopens the public docket to receive information on LASIK devices.

FDA Clears Platelet PGD Test System

[ Price : $8.95]

FDA clears Verax Biomedicals pooled platelet test system.

Social Media Hearing Tackles Adverse Event Reporting

[ Price : $8.95]

The second day of FDAs Internet Social Media hearing listens to stakeholders address how best to capture adverse event information...

Contaminants Possibly in Genzyme Products

[ Price : $8.95]

FDA notifies healthcare professionals about the potential for foreign particle contamination of several Genzyme products.

Age Range Expanded for CSL Flu Vaccine

[ Price : $8.95]

FDA says that a 2009 H1N1 flu vaccine produced by CSL Ltd. may be used in children over age six months as well as adults.

Regs Corrected on Genetically Engineered Animals

[ Price : $8.95]

Federal Register Notice: FDA corrects the heading in 21 CFR 500-599, page 359 on new animal drugs in genetically engineered animal...

Guidance on Registration for Tobacco Establishments

[ Price : $8.95]

Federal Register Notice: FDA releases a guidance Registration and Product Listing for Owners and Operators of Domestic Tobacco Pro...